<DOC>
	<DOCNO>NCT01644448</DOCNO>
	<brief_summary>This multicentre , open label , randomize , pilot study evalute safety efficacy Human Platelet Lysate ( HPL ) subject Periorbital Hyperpigmentation . The study conduct 2 center India.The primary endpoint Physicians Patient Self assessment score . The secondary endpoint improvement photographic assessment form randomization end study .</brief_summary>
	<brief_title>A Study Determine Safety &amp; Efficacy Autologous Human Platelet Lysate ( HPL ) Treatment Dark Circles</brief_title>
	<detailed_description />
	<mesh_term>Hyperpigmentation</mesh_term>
	<criteria>Subjects ( male female ) , age 18 55 year ( inclusive ) Periorbital Hyperpigmentation . Subject willing refrain treatment Periorbital Hyperpigmentation entire study duration . Subjects willing give inform consent adhere study protocol . Subjects age less 18 55 year Subjects history connective tissue disease . Subjects metabolic hematopoietic disorder Subjects unwilling unable comply study protocol . Subjects take concomitant therapy might interfere study result investigator 's opinion participate another trial past 30 day .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2012</verification_date>
</DOC>